Goldman Sachs’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69.6M | Sell |
|
|||||
|
2025
Q1 | $79.1M | Buy |
|
|||||
|
2024
Q4 | $61.3M | Buy |
|
|||||
|
2024
Q3 | $64.9M | Buy |
|
|||||
|
2024
Q2 | $48.1M | Sell |
|
|||||
|
2024
Q1 | $58.5M | Sell |
|
|||||
|
2023
Q4 | $61.4M | Sell |
|
|||||
|
2023
Q3 | $75M | Buy |
|
|||||
|
2023
Q2 | $74.3M | Buy |
|
|||||
|
2023
Q1 | $71.7M | Buy |
|
|||||
|
2022
Q4 | $61.7M | Sell |
|
|||||
|
2022
Q3 | $55.4M | Buy |
|
|||||
|
2022
Q2 | $51M | Sell |
|
|||||
|
2022
Q1 | $60.8M | Buy |
|
|||||
|
2021
Q4 | $50.9M | Buy |
|
|||||
|
2021
Q3 | $41.5M | Buy |
|
|||||
|
2021
Q2 | $30.7M | Buy |
|
|||||
|
2021
Q1 | $29.5M | Buy |
|
|||||
|
2020
Q4 | $29.1M | Sell |
|
|||||
|
2020
Q3 | $30.1M | Buy |
|
|||||
|
2020
Q2 | $18.4M | Buy |
|
|||||
|
2020
Q1 | $11.5M | Sell |
|
|||||
|
2019
Q4 | $39.1M | Sell |
|
|||||
|
2019
Q3 | $35.4M | Buy |
|
|||||
|
2019
Q2 | $9.24M | Sell |
|
|||||
|
2019
Q1 | $56.3M | Sell |
|
|||||
|
2018
Q4 | $85.8M | Buy |
|